Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC lowered its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 15.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,434 shares of the biotechnology company’s stock after selling 253 shares during the period. Exchange Traded Concepts LLC’s holdings in Axon Enterprise were worth $852,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in AXON. Zweig DiMenna Associates LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at $4,606,000. Berbice Capital Management LLC purchased a new position in Axon Enterprise during the 4th quarter valued at about $59,000. Cornerstone Wealth Management LLC acquired a new position in Axon Enterprise in the 4th quarter valued at about $260,000. Brighton Jones LLC purchased a new stake in Axon Enterprise during the fourth quarter worth about $480,000. Finally, Yeomans Consulting Group Inc. acquired a new stake in shares of Axon Enterprise during the fourth quarter worth about $434,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Up 5.4 %

Shares of NASDAQ:AXON opened at $637.53 on Wednesday. The firm has a 50 day simple moving average of $618.29 and a 200-day simple moving average of $476.64. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $48.61 billion, a PE ratio of 164.74, a P/E/G ratio of 6.09 and a beta of 1.04.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Robert W. Baird lifted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. JMP Securities increased their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. Finally, Needham & Company LLC increased their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $524.85.

Insider Buying and Selling

In other news, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares in the company, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock worth $30,721,337 in the last ninety days. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.